Arden Trust’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-8,172
| Closed | -$1.28M | – | 331 |
|
|
2020
Q4 | $1.28M | Sell |
8,172
-1,180
| -13% | -$152K | 0.21% | 98 |
|
|
2020
Q3 | $1.07M | Buy |
9,352
+776
| +9% | +$83.7K | 0.19% | 106 |
|
|
2020
Q2 | $963K | Buy |
8,576
+112
| +1% | +$11.9K | 0.18% | 114 |
|
|
2020
Q1 | $760K | Buy |
8,464
+1,111
| +15% | +$109K | 0.15% | 123 |
|
|
2019
Q4 | $795K | Sell |
7,353
-838
| -10% | -$89.6K | 0.12% | 162 |
|
|
2019
Q3 | $802K | Buy |
8,191
+35
| +0.4% | +$3.94K | 0.13% | 156 |
|
|
2019
Q2 | $1.07M | Buy |
8,156
+51
| +0.6% | +$6.57K | 0.18% | 125 |
|
|
2019
Q1 | $1.09M | Buy |
8,105
+2,421
| +43% | +$301K | 0.18% | 134 |
|
|
2018
Q4 | $553K | Sell |
5,684
-1,518
| -21% | -$179K | 0.1% | 191 |
|
|
2018
Q3 | $1M | Sell |
7,202
-287
| -4% | -$36K | 0.16% | 138 |
|
|
2018
Q2 | $930K | Buy |
7,489
+1,444
| +24% | +$169K | 0.15% | 144 |
|
|
2018
Q1 | $673K | Buy |
6,045
+298
| +5% | +$35.6K | 0.1% | 187 |
|
|
2017
Q4 | $687K | Buy |
5,747
+482
| +9% | +$58.7K | 0.1% | 181 |
|
|
2017
Q3 | $738K | Sell |
5,265
-124
| -2% | -$16.8K | 0.11% | 184 |
|
|
2017
Q2 | $655K | Sell |
5,389
-418
| -7% | -$48.6K | 0.1% | 195 |
|
|
2017
Q1 | $704K | Sell |
5,807
-3,459
| -37% | -$446K | 0.11% | 177 |
|
|
2016
Q4 | $1.13M | Buy |
9,266
+529
| +6% | +$64.7K | 0.17% | 119 |
|
|
2016
Q3 | $1.07M | Sell |
8,737
-1,791
| -17% | -$231K | 0.16% | 122 |
|
|
2016
Q2 | $1.23K | Buy |
10,528
+4,608
| +78% | +$654K | 0.09% | 208 |
|
|
2016
Q1 | $824K | Buy |
5,920
+4,294
| +264% | +$630K | 0.07% | 284 |
|
|
2015
Q4 | $310K | Buy |
1,626
+56
| +4% | +$9.78K | 0.03% | 456 |
|
|
2015
Q3 | $246K | Buy |
+1,570
| New | +$286K | 0.02% | 581 |
|
Other funds holding ALXN
FCM
HI
PCM
DKCM
BBA
